Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics

NCT01657760 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT01657760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01657760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics
Lead sponsor
VA Office of Research and Development
Phase
Phase 1
Overall status
Completed
Start date
May 1, 2014
Completion date
September 1, 2017
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence